ArticleFrontiers in medicine2025
Emphysema-related mortality rates in the U.S. from 1999 to 2022.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bronchus and lung cancer-related mortality trends in the United States from 1999 to 2023.Journal of cardiothoracic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pulmonary emphysema is a progressive lung disease characterized by persistent respiratory symptoms that are a result of destruction to the alveoli wall and enlargement of distal airspaces. Despite initiatives made to create awareness about the dangers of smoking, and a nationwide reduction in cigarette smoking, emphysema (COPD) is still the third leading cause of death in the United States. Methods: This study utilized the CDC WONDER national database to investigate the trends in emphysema-related mortality in the United States. Age-adjusted mortality rates per 100,000 people (AAMR), annual percentage change (APC), and average annual percentage change (AAPC) with 95% confidence intervals (CIs) were assessed. The Joinpoint Regression Program was used to determine mortality trends between 1999 and 2022. Data extracted for analysis in this study includes gender, race/ethnicity, age groups, regions, states, and urban/rural classification. Results: From 1999 to 2022, there were 526,545 deaths due to emphysema in the United States. Overall age-adjusted mortality rates (AAMR) in the United States decreased from 18.47 in 1999 to 7.75 in 2022, with an average annual percentage change (AAPC) of -3.698. Emphysema caused 296,859 deaths in males and 229,686 in females in the United States. White populations had the highest AAMR over this period and the largest reduction in AAMR. AAMRs were initially highest in urban areas compared to rural regions. 85 + years had the highest crude mortality rate of 123.11 in 1999. Discussion: Emphysema-related deaths in the United States decreased overall between 1999 and 2022, likely a result of a greater emphasis on health education concerning the significant dangers of smoking and policy changes that made cigarettes less accessible and less affordable, and more available access to resources and support networks. Conclusion: It is important to address possible health disparities that exist among populations and improve healthcare outcomes and resource allocation among all population groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.